SAO · DASA3.SA
Diagnósticos da América S.A.
R$3.01+R$0.06 (+2.03%)
Diagnósticos da América S.A.’s quoted price sits in the lower half of its reported 52-week range, 48.01% below the high.
Loading market information…
SAO · PNVL3.SA · BRL
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 07:54 PM UTC. Cached market data; not a live quote.
One-year closing-price history · BRL. Historical prices are not a forecast.
Dimed S.A. Distribuidora de Medicamentos’s quoted price sits in the lower half of its reported 52-week range, 38.93% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Dimed S.A. Distribuidora de Medicamentos’s forward annual dividend is R$0.48 per share, paid quarterly. The forward yield is 4.77% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Dimed S.A. Distribuidora de Medicamentos’s next earnings report is currently expected on Nov 5, 2026, with estimated earnings per share of R$0.32. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Dimed S.A. Distribuidora de Medicamentos’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Headquartered in Eldorado do Sul, Brazil, Dimed S.A. Distribuidora de Medicamentos is a Brazilian company that supplies a wide range of goods, including pharmaceuticals, fragrances, personal care products, cosmetics, and dermocosmetics. Its business model encompasses both retail and wholesale operations. The company distributes its merchandise through logistical hubs situated in the states of Rio Grande do Sul, Paraná, and Espírito Santo. Furthermore, it boasts an extensive retail network of 517 stores, located across Rio Grande do Sul, Santa Catarina, Paraná, and São Paulo. Before April 2000, the company was known as Panvel S.A. Drogarias e Farmacias.
Latest available per-share figures in BRL. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:17 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| R$1.34B-2.41% vs estimate |
| Q4 2024 | Mar 13, 2025 | R$0.21 | R$1.35B-6.05% vs estimate |
|---|
| Q3 2024 | Nov 13, 2024 | R$0.24 | R$1.33B+0.47% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
R$3.01+R$0.06 (+2.03%)
Diagnósticos da América S.A.’s quoted price sits in the lower half of its reported 52-week range, 48.01% below the high.
R$9.14-R$0.21 (-2.25%)
Blau Farmacêutica S.A.’s quoted price sits in the lower half of its reported 52-week range, 36.97% below the high.
R$2.51-R$0.05 (-1.95%)
Empreendimentos Pague Menos S.A.’s quoted price sits in the lower half of its reported 52-week range, 67.06% below the high.
R$0.77+R$0.06 (+8.45%)
Oncoclínicas do Brasil Serviços Médicos S.A.’s quoted price sits in the lower half of its reported 52-week range, 74.92% below the high.
R$6.69+R$0.09 (+1.36%)
Profarma Distribuidora de Produtos Farmacêuticos S.A.’s quoted price sits in the lower half of its reported 52-week range, 31.03% below the high.
R$5.38+R$0.03 (+0.56%)
Biomm S.A.’s quoted price sits in the lower half of its reported 52-week range, 44.82% below the high.
R$2.47+R$0.01 (+0.41%)
Allianca Saude e Participacoes S.A.’s quoted price sits in the lower half of its reported 52-week range, 60.1% below the high.
R$1.32+R$0.02 (+1.54%)
Qualicorp Consultoria e Corretora de Seguros S.A.’s quoted price sits in the lower half of its reported 52-week range, 51.65% below the high.
